Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTV-guided tacrolimus dosing versus standard tacrolimus dosing after kidney transplantation
2022-500024-30-00Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, open-label trial of tacrolimus in kidney transplant (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Primary composite endpoint. Started Aug 2022; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2022-500024-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500024-30-00.